Expression of p27(kip1) in prostatic adenocarcinoma

Modern Pathology

Volumn 11, Issue 4, 1998, Pages 324-328

  Cheville, John C ^a   Lloyd, Ricardo V ^a   Sebo, Thomas J ^a   Cheng, L ^a   Erickson, Lori ^a   Bostwick, David G ^a   Lohse, Christine M ^a   Wollan, Peter ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adenocarcinoma; p27; Prostate; Sub clinical biochemical failure

Indexed keywords

PROTEIN P27; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ENZYME INHIBITOR; MICROTUBULE ASSOCIATED PROTEIN; PROSTATE SPECIFIC ANTIGEN; TUMOR SUPPRESSOR PROTEIN;

ADULT; ANEUPLOIDY; ARTICLE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; PROTEIN EXPRESSION; SEMINAL VESICLE DISEASE; ADENOCARCINOMA; BLOOD; CANCER STAGING; CELL NUCLEUS; CHEMISTRY; DRUG ANTAGONISM; FAMILY HEALTH; GENE EXPRESSION; GENETICS; LYMPH NODE; METABOLISM; MIDDLE AGED; PATHOLOGY; PLOIDY; PROSTATE TUMOR; SEMINAL VESICLE; TIME; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANEUPLOIDY; CELL CYCLE PROTEINS; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; FAMILY HEALTH; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PLOIDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SEMINAL VESICLES; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0031596542     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. MacLachlan TK, Sang N, Giordano A. Cyclins, cyclin-dependent kinases, and CDK inhibitors: implications in cell cycle control and cancer. Crit Rev Eukaryot Gene Expr 1995;5:127-56.
2. kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994;372:570-3.
3. kip1 accumulation during the cell cycle. Science 1996;271:1861-4.
4. Pagano M, Tam SW, Theodoras AM, Romero-Beer P, Del Sal G, Chau V, et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995;269:682-5.
5. kip1 and cyclin E, alone and in combination, correlates with survival in young breast cancer patients. Nat Med 1997;3:222-5.
6. kip1 protein: prognostic implications in primary breast cancer. Nat Med 1997;3:227-30.
7. Tan P, Cady B, Wanner M, Worland P, Cukor B, Magi-Galluzzi C, et al The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a, b) invasive breast carcinomas. Cancer Res 1997;57:1259-63.
8. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med 1997;3:231-4.
9. Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K, et al. p27 expression and gastric carcinoma. Nat Med 1997;3:593.
10. Esposito V, Baldi A, De Luca A, Groger AM, Loda M, Giordano GG, et al. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 1997;57:3381-5.
11. Bostwick DG, Montironi R. Evaluating radical prostatectomy specimens: therapeutic and prognostic importance. Virchows Arch 1997;430:1-16.
12. Bostwick DG, Myers RP, Oesterling JE. Staging of prostate cancer. Semin Surg Oncol 1994;10:60-70.
13. Hedley D, Freidlander M, Taylor I, Rugg C, Musgrove E. Method for analysis of cellular DNA content of paraffin-embedded pathologic material using flow cytometry. J Histochem Cytochem 1983;31:1333-5.
14. Winkler HZ, Rainwater LM, Myers RP, Farrow GM, Therneau TM, Zincke H, et al. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry. Mayo Clin Proc 1988;63:103-12.
15. kip1 expression in endocrine and other tumors. Am J Pathol 1997;150:401-7.
16. Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression after radical prostatectomy. Cancer 1993;71:3582-93.
17. kip1 expression in nontumorous and neoplastic human pituitaries. Am J Pathol 1997;151:509-19.
18. kip1 and Ki-67 in benign and malignant thyroid tumors. Mod Pathol 1998;11:169-74.
19. kip1 gene to 12p13 and its analysis in leukemias. Cancer Res 1995;55: 1206-10.
20. kip1 chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 1995;55:1211-4.
21. kip1 in human malignancies. Cancer Res 1995;55:2266-9.
22. kip1 mutation found in breast cancer. Cancer Res 1996;56:2400-4.